Paris-based biopharma private equity fund Jeito Capital has appointed Sarah Leroy to the newly created position of secretary general, responsible for managing legal and financial affairs, compliance, HR and sustainability. She also becomes a member of the firm’s executive committee.

Leroy has more than 25 years’ experience. She is a member of the Paris Bar and began her career in the M&A teams of international law firms Jones Day and August Debouzy, In 2003, she joined AXA IM Alts, the alternative asset management company, as head of legal – corporate finance, before becoming global head of legal and a member of its executive committee in 2011. In 2018 Leroy joined Tereos, the cooperative group and sugar  producer, as legal, tax, compliance and insurance director, a member of the executive committee and a board member of several subsidiaries. Last year she was also put in charge of HR and appointed secretary to the nomination and remuneration committee.

Dr Rafaèle Tordjman, founder and chief executive of Jeito Capital, said: [Leroy’s] appointment marks a new stage in our growth dynamic. The creation of this new position reflects our desire to combine the efforts of our teams with those of our cross-functional teams to amplify value creation at Jeito Capital and its portfolio companies. Our portfolio companies from France and the United States all serve a common and ambitious objective: to accelerate therapeutic innovation for the benefit of patients.”

Leroy added: “I’m delighted to be joining the Jeito team and contributing to its expansion alongside its team of experts dedicated to collectively make a difference for patients. I’d like to thank Rafaèle for her trust and I’m looking forward to developing innovation with a strong human and social impact.”